VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q3 2024

Type / Class
Equity / COM NEW
Symbol
VTGN on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$9,314,499 0
2024 Q2 2,676,580 $9,314,499 $3.48 1
2024 Q1 2,676,580 $14,132,343 $5.28 1
2023 Q4 2,676,580 $13,757,621 +$13,757,621 $5.14 1
2023 Q3 0 $0 -$9,163 0
2023 Q2 4,900 $9,163 -$4,919,265 $1.87 1
2023 Q1 38,354,600 $4,783,347 -$222,623 $0.12 78
2022 Q4 40,184,918 $4,136,632 -$2,115,841 $0.10 76
2022 Q3 55,783,408 $8,483,975 -$75,876,320 $0.15 80
2022 Q2 138,753,453 $122,092,501 +$333,612 $0.88 107
2022 Q1 135,353,273 $167,810,413 -$4,484,424 $1.24 114
2021 Q4 138,154,113 $269,224,050 +$11,071,234 $1.95 105
2021 Q3 131,411,960 $360,231,784 +$21,554,869 $2.74 101
2021 Q2 123,478,533 $388,960,931 +$60,504,301 $3.15 98
2021 Q1 105,704,685 $225,150,557 +$83,042,131 $2.13 70
2020 Q4 67,294,590 $130,551,000 +$117,945,812 $1.94 49
2020 Q3 3,385,267 $2,359,000 +$678,728 $0.70 25
2020 Q2 2,440,539 $1,283,000 +$97,382 $0.52 22
2020 Q1 2,234,248 $982,000 -$186,988 $0.44 18
2019 Q4 2,493,797 $1,722,000 -$885,795 $0.69 23
2019 Q3 3,779,596 $4,044,000 +$1,006,464 $1.07 21
2019 Q2 3,197,244 $2,319,000 -$3,251,822 $0.72 20
2019 Q1 6,225,213 $7,969,000 +$3,927,773 $1.28 24
2018 Q4 3,116,701 $4,676,750 +$717,899 $1.50 20
2018 Q3 2,622,974 $3,801,725 +$310,659 $1.45 16
2018 Q2 2,293,655 $3,135,685 +$389,863 $1.37 19
2018 Q1 2,174,966 $2,016,383 -$2,549,103 $0.93 18
2017 Q4 4,708,425 $5,228,000 +$3,270,988 $1.11 14
2017 Q3 1,742,612 $2,785,000 +$805,594 $1.60 12
2017 Q2 1,233,416 $2,304,000 -$256,039 $1.86 13
2017 Q1 1,369,324 $2,681,000 -$1,240,484 $1.96 11
2016 Q4 1,681,883 $6,272,000 -$373,878 $3.73 12
2016 Q3 1,780,391 $7,454,000 +$18,959 $4.17 12
2016 Q2 1,778,904 $6,939,000 +$6,939,000 $3.90 10